comparemela.com

Latest Breaking News On - Oxurion - Page 7 : comparemela.com

Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS

Oxurion NV: Oxurion Issues EUR 2 0 million in Bonds for Tranche 1 (B) of the Funding Program with Atlas Special Opportunities LLC

Leuven, BELGIUM, Boston, MA, US - April 27, 2023 - 7:00 pm CET - Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies,

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC

Regulated Information Leuven, BELGIUM, Boston, MA, US – April 24, 2023 – 8.00 PM CET Oxurion NV a biopharmaceutical company developing next generation standard of care. | April 24, 2023

Aurion Announces DTC Eligibility of its Common Shares on the OTC Markets

ST. JOHN S, NL, April 17, 2023 /CNW/ - Aurion Resources Ltd.  announces that its common shares are now eligible for electronic clearing and settlement in the United States through the. | April 17, 2023

Oxurion NV: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated Information Leuven, BELGIUM, Boston, MA, US - April 14, 2023 - 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.